Search

Your search keyword '"de José MI"' showing total 73 results

Search Constraints

Start Over You searched for: Author "de José MI" Remove constraint Author: "de José MI"
73 results on '"de José MI"'

Search Results

1. Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009

2. Salvage Therapy With Abacavir and Other Reverse Transcriptase Inhibitors for Human Immunodeficiency-Associated Encephalopathy

3. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery

4. Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe

5. Comparison of levels of antiretroviral drugs with efficacy in children with HIV infection

6. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children

7. Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals

8. Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers

11. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children

12. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence.

13. Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy.

14. Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.

15. Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.

16. [Psychosocial aspects in a cohort of vertically transmitted human immunodeficiency virus-infected adolescents].

17. Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012.

18. Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities.

19. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome.

20. Subclinical atherosclerosis and markers of immune activation in HIV-infected children and adolescents: the CaroVIH Study.

21. Oseltamivir treatment for influenza in hospitalized children without underlying diseases.

22. Implementation of occult hepatitis screening in the Spanish cohort of HIV-infected pediatric patients.

23. Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects.

24. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults.

25. Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007.

26. High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.

27. Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients.

28. [Recommendations issued by the Spanish Society of Pediatric Infectious Diseases for the follow-up of the child exposed to the human immunodeficiency virus and to antiretroviral drugs during pregnancy and the neonatal period].

29. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents.

30. High drug resistance prevalence among vertically HIV-infected patients transferred from pediatric care to adult units in Spain.

31. Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease.

32. Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome.

33. [In-utero antiretroviral exposure and mitochondrial toxicity in a cohort of uninfected infants born to HIV-1-infected women].

34. Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy.

35. Impact of immigration on pulmonary tuberculosis in Spanish children: a three-decade review.

36. Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients.

37. Congenital syphilis, case report and epidemiologic features in Spain.

38. [Plasma antiretroviral levels in children with human immunodeficiency virus infection. Influence of sex and age].

39. Short communication: evaluation of the effect of enfuvirtide in 11 HIV-1 vertically infected pediatric patients outside clinical trials.

40. Impact of highly active antiretroviral therapy (HAART) on AIDS and death in a cohort of vertically HIV type 1-infected children: 1980-2006.

41. Pathology in children of HIV women.

42. [Growth of uninfected infants exposed to antiretrovirals born to HIV-infected woman].

43. [Birth defects in a cohort of uninfected children born to HIV-infected women].

44. [Anaemia and neutropenia in a cohort of non-infected children of HIV-positive mothers].

45. Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy.

46. Spatial pattern of HIV-1 mother-to-child-transmission in Madrid (Spain) from 1980 till now: demographic and socioeconomic factors.

47. Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin.

48. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children.

49. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children.

50. [Prevalence of resistance to antiretroviral drugs in Spain].

Catalog

Books, media, physical & digital resources